XENCOR
Xencor provides protein engineering technology platforms in the biotechnology industry. Its products include antibody therapeutics, such as XmAb2513 for the treatment of relapsed Hodgkin’s lymphoma and anaplastic large cell lymphoma; XmAb5574, a humanized monoclonal antibody that targets the antigen CD19 for the treatment of B cell malignancies; XmAb5592 for the treatment of myeloma; and XmAb5871 and XmAb7195, which are humanized monoclonal antibodies for the treatment of asthma and allergy. The company’s products also include XPro protein therapeutics, such as XPro1595, a dominant-negative inhibitor for the treatment of multiple animal models of autoimmune and neuroinflammatory diseases.
XENCOR
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
1997-01-01
Address:
Monrovia, California, United States
Country:
United States
Website Url:
http://www.xencor.com
Total Employee:
51+
Status:
Active
Contact:
626-305-5900
Total Funding:
133.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Domain Not Resolving Wordpress Plugins Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Applied Molecular Transport
Applied Molecular Transport developing novel, oral biological therapeutics to treat severe autoimmune, metabolic and inflammatory diseases.
Cerulean Pharma
Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Kinnate Biopharma
Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Nimbus Therapeutics
Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company.
Vetigenics
Vetigenics discovers and develops antibody-based immunotherapies to treat cancer and chronic diseases in companion animals
Zebra Biologics
Zebra Biologics develops bio superior agonist and antagonist antibody therapeutics for many diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Series E - Xencor
Novo Nordisk
Novo Nordisk investment in Series E - Xencor
Merlin Nexus
Merlin Nexus investment in Series E - Xencor
Zen Investments
Zen Investments investment in Series D - Xencor
Moore Capital
Moore Capital investment in Series C - Xencor
Sands Brothers Asset Management
Sands Brothers Asset Management investment in Series C - Xencor
Stafford Capital Partners
Stafford Capital Partners investment in Series C - Xencor
Stafford Capital Partners
Stafford Capital Partners investment in Series B - Xencor
Official Site Inspections
http://www.xencor.com Semrush global rank: 1.74 M Semrush visits lastest month: 13.58 K
Unable to get host informations!!!
More informations about "Xencor"
About Us - Xencor
Before Xencor, Mr. Cornelissen was vice president, corporate finance at Seagen Inc., where he built and scaled the corporate finance organization to support tremendous revenue growth and …See details»
Xencor - Crunchbase Company Profile & Funding
Xencor provides protein engineering technology platforms in the biotechnology industry. Its products include antibody therapeutics, such as XmAb2513 for the treatment of relapsed Hodgkin’s lymphoma and anaplastic large cell …See details»
Xencor, Inc. Company Profile | Pasadena, CA - Dun & Bradstreet
Company Description: Xencor is a clinical-stage biopharmaceutical company focused on discovering and developing engineered monoclonal antibodies and cytokine therapeutics to …See details»
Xencor, Inc. (XNCR) Company Profile & Facts - Yahoo Finance
See the company profile for Xencor, Inc. (XNCR) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»
Xencor - Funding, Financials, Valuation & Investors - Crunchbase
Xencor is registered under the ticker NASDAQ:XNCR . Their stock opened with $5.50 in its Dec 6, 2013 IPO. Xencor is funded by 7 investors. Oxford Bioscience Partners and Novo Nordisk are …See details»
Careers - Xencor
Or mail to Xencor: 111 W. Lemon Ave., Monrovia CA 91016. CONTACT US. [email protected] [email protected]. Xencor Headquarters 465 North Halstead Street, Suite 200 …See details»
Xencor Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 Xencor has 5 employees across 2 locations and $168.34 m in annual revenue in FY 2023. See insights on Xencor including office locations, competitors, revenue, financials, …See details»
X e n c or, I n c . F O R M 10-Q S E C U R I T I E S A N D E X C H A …
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 465 Nor th H al s te ad Stre e t, Sui te 200, P as ade na, CA 91107 (Address of principal executive …See details»
Xencor - The Org
Xencor. 1 follower Xencor develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer. ...See details»
Corporate Responsibility Statement - Xencor, Inc.
Xencor Corporate Responsibility Statement – April 2021 4 . Our Community . In 2020, we partnered with the Los Angeles Chapter of the . Leukemia & Lymphoma Society (LLS). The …See details»
Xencor - Contacts, Employees, Board Members, Advisors & Alumni …
Organization. Xencor . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 8. Number of Board …See details»
Xencor Announces Upcoming Change to Board of Directors
PASADENA, Calif., October 04, 2024--Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and …See details»
Proteins by Design - Xencor, Inc.
Xencor’s Disciplined Drug Development Strategy Validated Best-in-Class XmAb® Optimally Engineered Novel Drug CandidatesPlatforms Maximize Outcomes for All Stakeholders …See details»
Xencor - Golden
Xencor. A biopharmaceutical company, focused on the discovery and development of monoclonal antibody therapeutics to treat autoimmune, allergic diseases and cancer. Overview Structured …See details»
Xencor, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Xencor, Inc. with its drug pipeline, therapeutic area, technology platform, 33 clinical trials, 256 news, and 88 literature, Disease Domain:Neoplasms, Immune System Diseases, …See details»
Xencor | Pipeline
Xencor Headquarters 465 North Halstead Street, Suite 200 Pasadena, CA 91107 (626) 305-5900See details»
Working At Xencor: Company Overview and Culture - Zippia
Mar 14, 2024 Xencor, Inc. provides protein engineering technology platforms in the biotechnology industry. Its products include antibody therapeutics, such as XmAb2513 for the …See details»
Celia Eckert, J.D. - Xencor
May 6, 2016 Ms. Eckert joined Xencor as vice president, general counsel and corporate secretary in September 2019. Previously, she served as vice president, corporate legal at …See details»
Amgen And Xencor Announce Strategic Collaboration In Cancer ...
Xencor Announces Strategic Collaboration with Novartis for Bispecific Programs,... Terrific bispecifics crash CAR T party: Watch data mature, says Xencor CEO. Scroll to top. This site …See details»